iiinova — where your digital self keeps evolving

Reposted by Lina Meng, PharmD

IDSA @idsainfo.bsky.social · 22/05/2026

ID Pharmacists play an essential role in health systems. This #IDPharmacistsDay, learn five ways that pharmacists are being #AntibioticsAware via SIDP. For more sharable resources, visit sidp.org/AMSToolkit.

195

Reposted by Lina Meng, PharmD

ASHE Journal @ashejournal.bsky.social · 02/02/2026

Gut check: This review highlights stewardship opportunities in intra-abdominal infections, focusing on SBP prophylaxis, antibiotic management of biliary infections and appendicitis, and optimizing amoxicillin-clavulanate and metronidazole dosing. doi.org/10.1017/ash....

doi.org

Gut check: antimicrobial stewardship opportunities in intra-abdominal infections | Antimicrobial Stewardship & Healthcare Epidemiology | Cambridge Core

Gut check: antimicrobial stewardship opportunities in intra-abdominal infections - Volume 6 Issue 1

043

Reposted by Lina Meng, PharmD

ASHE Journal @ashejournal.bsky.social · 27/01/2026

Creating an advanced practice provider-led Complex Outpatient Antimicrobial Therapy program at our institute improved post-discharge follow-up, strengthened outpatient antimicrobial monitoring and supported timely outpatient interventions for patients with complex infection. doi.org/10.1017/ash....

doi.org

Can implementation of a complex outpatient antimicrobial therapy program reduce readmissions for patients with bone and joint infections? | Antimicrobial Stewardship & Healthcare Epidemiology | Cambridge Core

Can implementation of a complex outpatient antimicrobial therapy program reduce readmissions for patients with bone and joint infections? - Volume 6 Issue 1

011

Reposted by Lina Meng, PharmD

Open Forum Infectious Diseases @ofidjournal.bsky.social · 26/01/2026

Feeling the Vibes: An Investigation into Resident Antibiotic Prescribing Practices ✅ Just Accepted 🔗 bit.ly/4ablBjg

142

Reposted by Lina Meng, PharmD

Stanford Medicine, Infectious Diseases @stanford-med-id.bsky.social · 05/12/2025

A warm welcome to our new fellows! We are thrilled to have you on our team, here’s to an exciting journey ahead! Welcome to Stanford ID! #WelcomeFellows #InfectiousDiseases

172

Reposted by Lina Meng, PharmD

Stanford Antimicrobial Safety & Sustainability Program @stanfordasp.bsky.social · 23/10/2025

🩺 Clinically, identifying a lactose fermenting GNR is particularly useful for ruling out Pseudomonas. ⚠️ Many non-lactose fermenters (especially Stenotrophomonas, Burkholderia, and Acinetobacter) can be very challenging to treat. ID consultation should be considered for invasive infections.

041

Reposted by Lina Meng, PharmD

Stanford Antimicrobial Safety & Sustainability Program @stanfordasp.bsky.social · 15/10/2025

🌟 ABX Pearl of the Day: ❓ Q: When should I empirically cover for Pseudomonas aeruginosa in diabetic foot infections (DFIs)? #IDsky #medsky #meded #pharmsky #skyRX #AMSsky

173

Reposted by Lina Meng, PharmD

Stanford Antimicrobial Safety & Sustainability Program @stanfordasp.bsky.social · 24/09/2025

🌟 ABX Pearl of the Day: ❓ Q: Candida only grew in 1/4 bottles. Is this a contaminant? #IDsky #medsky #meded #pharmsky #skyRX #AMSsky

173

Reposted by Lina Meng, PharmD

Marisa Holubar, MD MS FIDSA @marisa-holubar.bsky.social · 24/09/2025

Yay! Tara's our awesome ASP track fellow this year - so lucky to get to work with her! @stanfordasp.bsky.social @linameng.bsky.social @dhpharmd.bsky.social @polishmd.bsky.social

021

Lina Meng, PharmD @linameng.bsky.social · 18/09/2025

Is empiric MRSA and PsA coverage needed for all moderately ICH with pneumonia? A recent study in CID offers a data-driven look. So what to do? Check out our ABX pearl on which ICH patients are best candidates for expanded empiric ABX coverage in CAP. ✅ #amssky #Idsky #medsky #pharmsky

academic.oup.com

Target Trial Emulation of Empiric Antibiotics on Clinical Outcomes in Moderately Immunocompromised Patients Hospitalized With Pneumonia

Empiric broad-spectrum antibiotic use for moderately immunocompromised patients without risk factors for multidrug-resistant organisms was associated with

141

Reposted by Lina Meng, PharmD

Stanford Antimicrobial Safety & Sustainability Program @stanfordasp.bsky.social · 10/09/2025

🌟 ABX Pearl of the Day: ❓ Q: My immunocompromised patient is admitted to the ICU and starting ABX for presumed CAP. Do they need empiric MRSA and Pseudomonas coverage? #IDsky #medsky #meded #pharmsky #skyRX #AMSsky

1113

Reposted by Lina Meng, PharmD

Stanford Antimicrobial Safety & Sustainability Program @stanfordasp.bsky.social · 17/09/2025

🌟 ABX Pearl of the Day: ❓ Q: My patient is growing yeast in blood cultures. Is this Candida? #IDsky #medsky #meded #pharmsky #skyRX #AMSsky

165

Reposted by Lina Meng, PharmD

Antibiotic Steward 🅱️C🆔🅿️🌟 @absteward.bsky.social · 17/07/2025

🔥Finally published🔥 IDSA Guidelines on the Treatment and Management of Complicated Urinary Tract Infections (cUTI) #idsky www.idsociety.org/practice-gui...

2258

Reposted by Lina Meng, PharmD

Sean Ong @seanong.bsky.social · 10/04/2025

Excited to share our newest paper from my PhD: a post-hoc analysis of the BALANCE trial where we explored heterogeneity of treatment effect (HTE) in duration of antibiotic treatment for patients with bloodstream infection. A thread: doi.org/10.1016/j.ec... #IDSky @eclinicalmed.bsky.social

doi.org

Redirecting

23515

Reposted by Lina Meng, PharmD

Stanford Antimicrobial Safety & Sustainability Program @stanfordasp.bsky.social · 18/04/2025

🌟 ABX Pearl of the Day: Linezolid drug interactions ❓ Q: I'd like to prescribe linezolid but my patient is on serotonergic agents. What is the incidence of serotonin syndrome with this combination? #IDsky #medsky #meded #pharmsky #skyRX

3167

Reposted by Lina Meng, PharmD

Julie Parsonnet @julieparsonnet.bsky.social · 20/03/2025

We're looking for a new Division Chief in Adult ID at Stanford. We have a great ID/Medicine family here and the division has been growing by leaps and bounds. We also have great Pedi ID, Micro, Immunology and Transplant teams. Please share!

075

Lina Meng, PharmD @linameng.bsky.social · 07/03/2025

Ongoing UCx stewardship efforts at Stanford 🤝 in partnership with infection control, CAUTI taskforce, micro lab, RNs ✔️ 2017: switch to UA with reflex only of wbc>10 ✔️2024: a creation of UCx order panel. 🚧 remove UA/UCx orders from surgery pre-op ordersets? #IDsky #AMSsky

041

Lina Meng, PharmD @linameng.bsky.social · 22/01/2025

#idsky #amssky Anyone using Tamiflu after IV peramivir in ICU patients that gain enteral access? Do people trust IV peramivir efficacy in severe/hospitalized flu? pubmed.ncbi.nlm.nih.gov/39181595/

pubmed.ncbi.nlm.nih.gov

Antivirals for treatment of severe influenza: a systematic review and network meta-analysis of randomised controlled trials - PubMed

World Health Organization.

030

Lina Meng, PharmD @linameng.bsky.social · 07/01/2025

I learned about this meropenem/VPA drug interaction the hard way as a new practitioner after unsuccessfully dose titrating VPA for days (and wasting 💰). Fortunately VPA indication was for alcohol withdrawal (non benzo ICU protocol at Stanford), not seizures! See useful tidbits on this interaction👇

120

Lina Meng, PharmD @linameng.bsky.social · 25/11/2024

For ceftriaxone-R Enterobacterales from blood, our micro report shows MIC but no interpretation. Instead, displays cautionary comment. Chance for ASP-micro lab collab! 🤝

250

Lina Meng, PharmD @linameng.bsky.social · 24/11/2024

Study shared by esteemed👇 on pyuria cutoff (in elderly♀️)"At a cutoff of 264 leuk/µL, sensitivity and specificity of microscopy were 88% (positive and negative likelihood ratio: 7.2 and 0.1, respectively). The commonly used cutoff of 10 leuk/µL had a poor specificity (36%) and a sensitivity of 100%."

110

Lina Meng, PharmD @linameng.bsky.social · 23/11/2024

Thrilled to see @conanmacdougall.bsky.social join! 🌟 Your insights are always spot-on. This graph on new ABX approval is spot on. 😂 So true about the emotional rollercoaster—though here, prescribers don't pay attention to drug cost unless formulary restricted. #IDsky #AMSsky #pharmsky #skyrx

0132

Lina Meng, PharmD @linameng.bsky.social · 22/11/2024

Love our peds ASP colleagues and their amazing tools! ♥️ One of our ED's go-to favorites is their pediatric Amox-Clav Dosing Guide—because seriously, who can keep track of all those doses and formulations/ratios? Welcome to Blue Sky! 🌟 #AMSsky #IDsky #pharmsky #skyRX #medsky

stanfordchildrens.org

Guidelines & Protocols

082

Lina Meng, PharmD @linameng.bsky.social · 22/11/2024

The look I get from SICU when I tell them they can stop ABX 24 hours after early GI perf repair 👀👽 #IDsky #pharmsky #AMSsky

0111

Lina Meng, PharmD @linameng.bsky.social · 20/11/2024

I sense a debate or update brewing for ID Week 2025/SIDP: team FQ vs b-lactam for uncomplicated GNR bacteremia? 🎙️👥 @idsainfo.bsky.social @sidpharm.bsky.social #IDsky

120

Lina Meng, PharmD @linameng.bsky.social · 20/11/2024

ID team Q: recs on amoxicillin PO dose for stepdown for uncomplicated strep bacteremia on day 5? Me: Pick anything. You're just about done with treatment! ...1g q8h #IDsky #medsky #pharmsky #RXsky

171

Lina Meng, PharmD @linameng.bsky.social · 18/11/2024

Back to ASP work on Monday, and it feels like everyone has aspirated over the weekend and is on ABX. 🫠 Perfect timing for this ABX pearl on distinguishing aspiration pneumonitis from pneumonia. 🔑 Hyperacute resolution? Skip the ABX. Check it out! 👇 #USAAW24 #AMSsky #IDsky #pharmsky #MedEd

153

Lina Meng, PharmD @linameng.bsky.social · 18/11/2024

Shout out to our amazing ASP team members @dhpharmd.bsky.social and @marisa-holubar.bsky.social for this fun idea! 🦠💜 Loving the micro nerd energy at Stanford for #USAAW24. 🙌 What’s everyone else doing this week? #IDsky #Medsky #pharmsky #amssky

051

Reposted by Lina Meng, PharmD

Lina Meng, PharmD @linameng.bsky.social · 15/11/2024

Need help! 🙏 #IDsky #Medsky #AMSsky @joshparkpharmd.bsky.social—looking for ideas/must-haves to build a simple ED dashboard 📊 for tracking ABX use & outcomes. We’re on Epic and keeping it basic for the first go. CC: @dhpharmd.bsky.social

173

Reposted by Lina Meng, PharmD

Antibiotic Steward 🅱️C🆔🅿️🌟 @absteward.bsky.social · 16/11/2024

Multiple RCTs comprised patients with gram negative bacteremia from predominantly urinary sources demonstrate noninferiority of 7 days compared with 14 total days of treatment for a variety of patient-oriented outcomes, such as clinical cure, clinical failure,relapse, and all-cause mortality. #idsky

182

Lina Meng, PharmD @linameng.bsky.social · 16/11/2024

Hi #IDsky & #PharmSky! 👋 I'm an ABX stewie (formerly critical care) at Stanford: ✨ Passionate about learning from others in ID, ASP, & RX. 🛠️ Love creating tools & education for frontline clinicians. 📚 Started Stanford ABX pearls series and Obesity ABX Guidance Excited to connect and share ideas!

med.stanford.edu

ABX Pearls

3222

Lina Meng, PharmD @linameng.bsky.social · 15/11/2024

🔄 Just got this consult question this week from our ICU pharmD—a great reminder during our blood culture and IV fluid shortages! 💡💊 Love it when I can reply back ✂️🗒️ with our team's ABX Pearl #IDsky #MedEd #pharmSky #RXsky 🔗ABX pearl library here: med.stanford.edu/bugsanddrugs...

med.stanford.edu

ABX Pearls

010

Lina Meng, PharmD @linameng.bsky.social · 15/11/2024

Just in time before the BCx bottle shortage—this team’s work in diagnostic stewardship was vital! 💪 Proud to have such amazing colleagues leading these efforts with Epic hard stops driving real impact. Congrats on the Award! 🏆👏 #IDsky #medsky #amssky @grod11.blsky.social @jlsalinas.blsky.social

151

Lina Meng, PharmD @linameng.bsky.social · 15/11/2024

New to Bluesky and #idsky! 🌌 Just followed my first feed and get why #idsky tags are key for keeping us all linked up! 🔑🤝 Thanks for the tutorial @kenkoonwong.bsky.social

061

Lina Meng, PharmD @linameng.bsky.social · 14/11/2024

These slides are 🔥—super well-curated topics 🎯by @polishmd.bsky.social-- many are already being or soon to be discussed at ID rounds and our hospital's P&T. Catch up here 📑✨" idac.org/Past-Events

idac.org

Infectious Disease Association of California - Past Events

142

Lina Meng, PharmD @linameng.bsky.social · 14/11/2024

🙋‍♀️ All my favorite people are here! (You too, @martenhawkins.bsky.social!) The @stanfordasp.bsky.social team has been notified—time to join the migration! 📣

021

Reposted by Lina Meng, PharmD

Stanford Antimicrobial Safety & Sustainability Program @stanfordasp.bsky.social · 13/11/2024

Starting off with a few ABX pearls based on the most common syndromes and topics that we encounter day-to-day. (Please note our website resources too!) 📑

2125

Lina Meng, PharmD @linameng.bsky.social · 13/11/2024

Feeling the ID community momentum to rebuild in John Dorsey's twin project.🙌 So far seems to offer a reprieve from X's extreme algorithms and related posts! And the starter packs are much appreciated @germhuntermd.bsky.social 🙏

030